Immunomodulation by imiquimod in patients with high-risk primary melanoma.
Narayan R, Nguyen H, Bentow JJ, Moy L, Lee DK, Greger S, Haskell J, Vanchinathan V, Chang PL, Tsui S, Konishi T, Comin-Anduix B, Dauphine C, Vargas HI, Economou JS, Ribas A, Bruhn KW, Craft N.
Narayan R, et al. Among authors: craft n.
J Invest Dermatol. 2012 Jan;132(1):163-9. doi: 10.1038/jid.2011.247. Epub 2011 Aug 18.
J Invest Dermatol. 2012.
PMID: 21850019
Free PMC article.
Clinical Trial.